(Q46629943)

23 December 2017

title

Memantine in the treatment of binge eating disorder: an open-label, prospective trial (English)

1 reference

23 December 2017

1 reference

1 reference

6

James I Hudson

1 reference

23 December 2017

author name string

Brian P Brennan

1

1 reference

23 December 2017

Jacqueline L Roberts

2

1 reference

23 December 2017

Kate V Fogarty

3

1 reference

23 December 2017

Karina A Reynolds

4

1 reference

23 December 2017

Jeffrey M Jonas

5

1 reference

23 December 2017

publication date

1 September 2008

1 reference

23 December 2017

International Journal of Eating Disorders

published in

1 reference

23 December 2017

volume

41

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

520-526

1 reference

23 December 2017

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

cites work

1 reference

The assessment of anxiety states by rating

21 January 2018

1 reference

Assessing psychiatric impairment in primary care with the Sheehan Disability Scale

21 January 2018

1 reference

Binge eating disorder: clinical features and treatment of a new diagnosis

21 January 2018

1 reference

7 January 2021

The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication

1 reference

7 January 2021

Co-occurrence of binge eating disorder with psychiatric and medical disorders

1 reference

7 January 2021

Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial

1 reference

7 January 2021

Placebo-controlled trial of sertraline in the treatment of binge eating disorder.

1 reference

7 January 2021

Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

1 reference

7 January 2021

A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating Disorder

1 reference

7 January 2021

Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study

1 reference

7 January 2021

Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial

1 reference

7 January 2021

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

1 reference

7 January 2021

Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study

1 reference

7 January 2021

A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder.

1 reference

7 January 2021

Psychological and dietary treatments of binge eating disorder: conceptual implications

1 reference

7 January 2021

A randomized controlled comparison of guided self-help cognitive behavioral therapy and behavioral weight loss for binge eating disorder

1 reference

7 January 2021

Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison

1 reference

7 January 2021

Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder

1 reference

7 January 2021

Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice.

1 reference

7 January 2021

Does High Glutamate Intake Cause Obesity?

1 reference

7 January 2021

The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating

1 reference

7 January 2021

Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats

1 reference

7 January 2021

A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders

1 reference

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

7 January 2021

Factor structure of the Barratt impulsiveness scale

1 reference

7 January 2021

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

1 reference

7 January 2021

Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.

1 reference

7 January 2021

Bulimia in obese individuals. Relationship to normal-weight bulimia

1 reference

7 January 2021

Memantine in moderate-to-severe Alzheimer's disease

1 reference

7 January 2021

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

1 reference

7 January 2021

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

1 reference

7 January 2021

Pharmacologic treatment of binge eating disorder

1 reference

7 January 2021

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

7 January 2021

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

1 reference

7 January 2021

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

1 reference

7 January 2021

Memantine augmentation for refractory obsessive-compulsive disorder.

1 reference

7 January 2021

Beneficial Effects of the Glutamate-modulating Agent Riluzole on Disordered Eating and Pathological Skin-picking Behaviors

1 reference

7 January 2021

Identifiers

DOI

10.1002/EAT.20541

1 reference

23 December 2017

1 reference

23 December 2017